Robert L. Myers - 25 Sep 2023 Form 4 Insider Report for Predictive Oncology Inc. (POAI)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Bob Myers
Issuer symbol
POAI
Transactions as of
25 Sep 2023
Net transactions value
-$1,510
Form type
4
Filing time
27 Sep 2023, 18:25:18 UTC
Previous filing
02 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction POAI Common Stock Options Exercise +1,667 +47% 5,230 25 Sep 2023 Direct F1, F2
transaction POAI Common Stock Tax liability $1,510 -510 -9.8% $2.96 4,720 25 Sep 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 23, 2020, the Reporting Person was granted 5,000 restricted stock units, vesting in three annual installments on each of September 23, 2021, September 23, 2022 and September 23, 2023.
F2 Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock. The shares are delivered to the Reporting Person upon vesting.
F3 510 shares of common stock withheld by the Company on September 25, 2023 to cover withholding tax, in accordance with Restricted Stock Unit Agreement between Reporting Person and Company.